Grace Therapeutics, Inc. SEC filings GRCE

Grace Therapeutics, Inc. has 594 filings in SEC EDGAR's recent list, going back to Sep 2, 2008. Its latest annual report, Form 10-K, was filed on Jun 18, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 18, 2026 (shareholder vote results). The company's fiscal year ends on March 31.

Grace Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Shareholder vote results
Sep 18, 2026 Sep 17, 2026
EFFECT Filing Aug 31, 2026 —
S-3 Shelf registration Aug 24, 2026 —
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
D Filing Aug 11, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 6, 2026 Aug 4, 2026
DEFA14A Additional proxy material Jul 28, 2026 —
DEF 14A Proxy statement Jul 28, 2026 Sep 17, 2026
8-K Current report
Other events
Jul 28, 2026 Jul 28, 2026
8-K Current report
Other events
Jun 18, 2026 Jun 18, 2026
8-K Current report
Results of operations
Jun 18, 2026 Jun 18, 2026
10-K Annual report Jun 18, 2026 Mar 31, 2026
8-K Current report
Officer or director change
Jun 5, 2026 Jun 1, 2026
8-K Current report
Other events
Apr 27, 2026 Apr 27, 2026
8-K Current report
Other events
Apr 23, 2026 Apr 23, 2026
8-K Current report
Results of operations
Feb 12, 2026 Feb 12, 2026
10-Q Quarterly report Feb 12, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Jan 12, 2026 Jan 10, 2026
10-Q/A Amended quarterly report Nov 17, 2025 Sep 30, 2025
8-K Current report
Results of operations, Other events
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Other events
Oct 23, 2025 Oct 23, 2025
8-K Current report
Other events
Sep 18, 2025 Sep 18, 2025
8-K Current report
Shareholder vote results
Sep 12, 2025 Sep 12, 2025
8-K Current report
Other events
Aug 27, 2025 Aug 27, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
DEFA14A Additional proxy material Jul 28, 2025 —
DEF 14A Proxy statement Jul 28, 2025 Sep 12, 2025
8-K Current report
Other events
Jun 25, 2025 Jun 25, 2025
8-K Current report
Results of operations
Jun 23, 2025 Jun 23, 2025
10-K Annual report Jun 23, 2025 Mar 31, 2025
8-K Current report
Other events
Apr 9, 2025 Apr 9, 2025
EFFECT Filing Mar 13, 2025 —
CORRESP Letter to the SEC Mar 12, 2025 —
UPLOAD Letter from the SEC Mar 11, 2025 —
S-3 Shelf registration Mar 10, 2025 —
8-K Current report
Other events
Mar 3, 2025 Mar 3, 2025
D Filing Feb 25, 2025 —
10-Q/A Amended quarterly report Feb 19, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 13, 2025 Feb 13, 2025
10-Q Quarterly report Feb 13, 2025 Dec 31, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Feb 10, 2025 Feb 10, 2025
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Bylaw or fiscal year change
Oct 28, 2024 Oct 24, 2024
8-K Current report
Other events
Oct 25, 2024 Oct 25, 2024
EFFECT Filing Oct 15, 2024 —
EFFECT Filing Oct 15, 2024 —
S-8 Employee stock plan registration Oct 8, 2024 —
S-8 POS Filing Oct 8, 2024 —
S-8 POS Filing Oct 8, 2024 —
S-8 POS Filing Oct 8, 2024 —
POS AM Filing Oct 8, 2024 —
POS AM Filing Oct 8, 2024 —
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
Oct 7, 2024 Oct 1, 2024
8-K Current report
Officer or director change, Shareholder vote results
Sep 30, 2024 Sep 30, 2024
8-K Current report
Other events
Sep 25, 2024 Sep 25, 2024
DEFA14A Additional proxy material Sep 6, 2024 —
8-K Current report
Officer or director change
Aug 16, 2024 Aug 12, 2024
8-K Current report
Results of operations
Aug 9, 2024 Aug 9, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
DEFA14A Additional proxy material Aug 7, 2024 —
424B3 Prospectus Aug 7, 2024 —
EFFECT Filing Aug 2, 2024 —
CORRESP Letter to the SEC Jul 31, 2024 —
S-4/A Filing Jul 31, 2024 —
UPLOAD Letter from the SEC Jul 3, 2024 —
S-4 Registration for a merger or exchange Jun 27, 2024 —
8-K Current report
Other events
Jun 27, 2024 Jun 27, 2024
8-K Current report
Results of operations
Jun 21, 2024 Jun 21, 2024
10-K Annual report Jun 21, 2024 Mar 31, 2024
8-K Current report
Regulation FD disclosure
Apr 1, 2024 Apr 1, 2024
8-K Current report
Results of operations
Feb 12, 2024 Feb 12, 2024
10-Q Quarterly report Feb 12, 2024 Dec 31, 2023
8-K Current report
Officer or director change
Jan 8, 2024 Jan 5, 2024
8-K Current report
Auditor change
Dec 15, 2023 Dec 11, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Material agreement, Other events
Oct 23, 2023 Oct 18, 2023
EFFECT Filing Oct 16, 2023 —
424B3 Prospectus Oct 16, 2023 —
CORRESP Letter to the SEC Oct 12, 2023 —
UPLOAD Letter from the SEC Oct 12, 2023 —
8-K Current report
Shareholder vote results
Oct 11, 2023 Oct 10, 2023
D Filing Oct 10, 2023 —
S-3 Shelf registration Oct 6, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 26, 2023 Sep 24, 2023
S-8 Employee stock plan registration Aug 25, 2023 —
DEFA14A Additional proxy material Aug 25, 2023 —
DEF 14A Proxy statement Aug 25, 2023 Oct 10, 2023
8-K Current report
Results of operations
Aug 11, 2023 Aug 11, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Other events
Jul 24, 2023 Jul 24, 2023
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Jul 7, 2023 Jul 4, 2023
8-K Current report
Other events
Jul 5, 2023 Jul 5, 2023
8-K Current report
Results of operations
Jun 23, 2023 Jun 23, 2023
10-K Annual report Jun 23, 2023 Mar 31, 2023
8-K Current report
Officer or director change, Other events
May 11, 2023 May 8, 2023
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Apr 5, 2023 Apr 4, 2023
8-K Current report
Officer or director change
Mar 31, 2023 Mar 30, 2023
8-K Current report
Regulation FD disclosure, Other events
Mar 13, 2023 Mar 13, 2023
8-K Current report
Auditor change
Feb 23, 2023 Feb 22, 2023
8-K Current report
Results of operations
Feb 14, 2023 Feb 14, 2023
10-Q Quarterly report Feb 14, 2023 Dec 31, 2022
8-K Current report
Other events
Jan 25, 2023 Jan 25, 2023
8-K Current report
Other events
Dec 28, 2022 Dec 28, 2022
8-K Current report
Other events
Dec 22, 2022 Dec 22, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Other events
Sep 30, 2022 Sep 30, 2022
8-K Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
Sep 29, 2022 Sep 28, 2022
DEF 14A Proxy statement Aug 31, 2022 Sep 28, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
10-K/A Amended annual report Jul 29, 2022 Mar 31, 2022
8-K Current report
Listing notice
Jul 29, 2022 Jul 27, 2022
424B3 Prospectus Jun 23, 2022 —
8-K Current report
Results of operations
Jun 21, 2022 Jun 21, 2022
10-K Annual report Jun 21, 2022 Mar 31, 2022
8-K Current report
Regulation FD disclosure, Other events
May 18, 2022 May 18, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 25, 2022 Mar 24, 2022
8-K Current report
Results of operations
Feb 14, 2022 Feb 14, 2022
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
8-K Current report
Regulation FD disclosure
Dec 2, 2021 Dec 2, 2021
8-K Current report
Regulation FD disclosure
Nov 15, 2021 Nov 12, 2021
424B5 Prospectus supplement Nov 10, 2021 —
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
8-K/A Amended current report Nov 5, 2021 Aug 26, 2021
8-K Current report
Regulation FD disclosure
Sep 22, 2021 Sep 22, 2021
8-K Current report
Bylaw or fiscal year change
Sep 9, 2021 Sep 7, 2021
8-K Current report
Acquisition or sale of assets, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
Aug 27, 2021 Aug 26, 2021
425 Filing Aug 12, 2021 —
8-K Current report
Results of operations
Aug 12, 2021 Aug 12, 2021
10-Q Quarterly report Aug 12, 2021 Jun 30, 2021
425 Filing Aug 4, 2021 —
425 Filing Aug 4, 2021 —
8-K Current report
Other events
Jul 23, 2021 Jul 23, 2021
425 Form 8-k Jul 23, 2021 —
8-K Current report
Other events
Jul 21, 2021 Jul 21, 2021
425 Form 8-k Jul 21, 2021 —
EFFECT Filing Jul 15, 2021 —
424B3 Prospectus Jul 15, 2021 —
CORRESP Letter to the SEC Jul 13, 2021 —
S-4/A Filing Jul 13, 2021 —
UPLOAD Letter from the SEC Jul 6, 2021 —
S-4 Registration for a merger or exchange Jul 1, 2021 —
10-K Annual report Jun 22, 2021 Mar 31, 2021
8-K Current report
Results of operations
Jun 22, 2021 Jun 22, 2021
8-K Current report
Listing notice, Other events
May 17, 2021 May 11, 2021
8-K Current report
Material agreement, Regulation FD disclosure, Other events
May 7, 2021 May 7, 2021
425 Form 8-k May 7, 2021 —
8-K Current report
Other events
Mar 9, 2021 Mar 8, 2021
8-K Current report
Results of operations
Feb 9, 2021 Feb 9, 2021
10-Q Quarterly report Feb 9, 2021 Dec 31, 2020
8-K Current report
Other events
Jan 27, 2021 Jan 27, 2021
8-K Current report
Other events
Dec 4, 2020 Dec 4, 2020
8-K Current report
Results of operations
Nov 16, 2020 Nov 16, 2020
10-Q Quarterly report Nov 16, 2020 Sep 30, 2020
8-K Current report
Listing notice
Oct 7, 2020 Oct 5, 2020
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
Oct 2, 2020 Sep 30, 2020
8-K Current report
Other events
Sep 29, 2020 Sep 29, 2020
8-K Current report
Officer or director change
Sep 18, 2020 Sep 14, 2020
8-K Current report
Officer or director change, Other events
Sep 11, 2020 Sep 11, 2020
DEFA14A Additional proxy material Sep 11, 2020 —
DEF 14A Proxy statement Sep 9, 2020 Sep 30, 2020
8-K Current report
Other events
Aug 31, 2020 Aug 31, 2020
10-Q Quarterly report Aug 13, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 13, 2020 Aug 13, 2020
PRE 14A Preliminary proxy statement Aug 7, 2020 Sep 30, 2020
8-K Current report
Regulation FD disclosure
Jul 31, 2020 Jul 31, 2020
EFFECT Filing Jul 7, 2020 —
424B5 Prospectus supplement Jul 7, 2020 —
CORRESP Letter to the SEC Jul 6, 2020 —
UPLOAD Letter from the SEC Jul 2, 2020 —
8-K Current report
Material agreement, Regulation FD disclosure
Jun 30, 2020 Jun 30, 2020
S-3 Shelf registration Jun 29, 2020 —
10-K Annual report Jun 29, 2020 Mar 31, 2020
8-K Current report
Results of operations
Jun 29, 2020 Jun 29, 2020
8-K Current report
Other events
Jun 19, 2020 Jun 19, 2020
8-K Current report
Regulation FD disclosure
Apr 30, 2020 Apr 30, 2020
8-K Current report
Regulation FD disclosure, Other events
Apr 20, 2020 Apr 17, 2020
8-K Current report
Regulation FD disclosure
Apr 1, 2020 Apr 1, 2020
6-K Current report (foreign issuer) Mar 11, 2020 Mar 11, 2020
6-K Current report (foreign issuer) Feb 28, 2020 Feb 28, 2020
6-K Current report (foreign issuer) Feb 14, 2020 Feb 14, 2020
6-K Current report (foreign issuer) Feb 14, 2020 Feb 13, 2020
6-K Current report (foreign issuer) Feb 13, 2020 Feb 13, 2020
6-K Current report (foreign issuer) Feb 10, 2020 Feb 10, 2020
6-K Current report (foreign issuer) Jan 13, 2020 Jan 13, 2020
6-K Current report (foreign issuer) Dec 24, 2019 Dec 23, 2019
6-K Current report (foreign issuer) Nov 26, 2019 Nov 26, 2019
6-K Current report (foreign issuer) Nov 18, 2019 Nov 18, 2019
6-K Current report (foreign issuer) Nov 13, 2019 Sep 30, 2019
6-K Current report (foreign issuer) Nov 13, 2019 Nov 13, 2019
6-K Current report (foreign issuer) Nov 7, 2019 Nov 7, 2019
6-K Current report (foreign issuer) Nov 6, 2019 Nov 6, 2019
6-K Current report (foreign issuer) Nov 4, 2019 Nov 4, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GRCE (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
Princeton, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1444192
Former names
Acasti Pharma Inc. (until Oct 25, 2024)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.